Argos Therapeutics IPO Research Information

Argos Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Argos Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Argos Therapeutics	ARGS - NASDAQ	$13.00-$15.00	$8.00	$8.90	5.63 million	2/7/2014
Underwriter(s): Piper Jaffray, Stifel, JMP Securities
Co-Manager(s): Needham & Co.
Industry: Health Care
Filing(s): Refiled 2013-12-30

Argos Therapeutics Quote & Chart - Click for current quote - ARGS

About Argos Therapeutics (adapted from Argos Therapeutics prospectus):
They are a biopharmaceutical company focused on the treatment of cancer and infectious diseases.

This description is adapted from Argos prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Argos "ARGS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.